Updated: May 20, 2021
As of May 5, 2021, Hospira has issued a recall of specific lots of 0.5% Bupivacaine Hydrochloride and Lidocaine HCL. If you have either lot EG6023 of 0.5% Bupivacaine Hydrochloride Injection, USP 0.5% 30 mL or lot EG8933 of Lidocaine HCl Injection USP, 1% 30 mL, it should be removed from stock immediately and the manufacturer (or the dealer through whom it was purchased) should be contacted. Hospira has identified mislabeling whereby a portion of each lot was incorrectly labeled as the other product. This issue was identified as part of the investigation of a confirmed customer report.
For further information, contact Hospira, or see the full report from the FDA.